Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Perioperative and Postoperative Analgesia
NCT03921567Phase 4Unknown
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lidocaine in postoperative pain (3 arms). Primary endpoint: Reduction of opiods used during perioperative period and other analgesics used during postoperative period at 48 hours. Status: unknown.
02
Drugs
lidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03921567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03921567.